MU Investments Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-620
Closed -$45K 73
2017
Q4
$45K Sell
620
-250
-29% -$19K 0.03% 48
2017
Q3
$70K Sell
870
-250
-22% -$19.1K 0.05% 40
2017
Q2
$79K Sell
1,120
-30
-3% -$2K 0.06% 45
2017
Q1
$78K Sell
1,150
-180
-14% -$12.7K 0.06% 63
2016
Q4
$96K Sell
1,330
-840
-39% -$62.4K 0.07% 51
2016
Q3
$169K Sell
2,170
-1,970
-48% -$160K 0.12% 44
2016
Q2
$341K Sell
4,140
-3,230
-44% -$287K 0.23% 39
2016
Q1
$678K Buy
7,370
+20
+0.3% +$1.8K 0.43% 32
2015
Q4
$747K Sell
7,350
-4,200
-36% -$437K 0.44% 35
2015
Q3
$1.11M Hold
11,550
0.6% 32
2015
Q2
$1.33M Sell
11,550
-600
-5% -$65.6K 0.64% 32
2015
Q1
$1.22M Buy
12,150
+610
+5% +$61.9K 0.57% 36
2014
Q4
$1.08M Buy
11,540
+650
+6% +$67.2K 0.47% 44
2014
Q3
$1.17M Sell
10,890
-4,680
-30% -$458K 0.58% 35
2014
Q2
$1.29M Sell
15,570
-1,200
-7% -$93.4K 0.59% 33
2014
Q1
$1.15M Sell
16,770
-1,400
-8% -$110K 0.53% 38
2013
Q4
$1.37M Sell
18,170
-2,080
-10% -$145K 0.59% 38
2013
Q3
$1.29M Sell
20,250
-8,750
-30% -$523K 0.62% 38
2013
Q2
$1.48M Buy
+29,000
New +$1.51M 0.63% 40

Other funds holding GILD

MU Investments Company's GILD Position: Q1 2018 in Review

MU Investments Company sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 620 shares — an estimated $45K sold.

MU Investments Company first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $1.48M in Q2 2013. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • MU Investments Company reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • MU Investments Company sold 620 Gilead Sciences shares in Q1 2018, an estimated $45K.
  • MU Investments Company first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
  • MU Investments Company's Gilead Sciences position peaked at $1.48M in Q2 2013.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on MU Investments Company's 13F filing for Q1 2018, filed 20 Apr 2018.